IMMUNOGEN INC
S-3/A, EX-5.1, 2000-11-15
PHARMACEUTICAL PREPARATIONS
Previous: IMMUNOGEN INC, S-3/A, 2000-11-15
Next: IMMUNOGEN INC, S-3/A, EX-23.1, 2000-11-15



<PAGE>
                                                                     EXHIBIT 5.1

                Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

                              One Financial Center
                          Boston, Massachusetts 02111

                                                                 617 542 6000

                                                                617 542 2241 FAX

                               November 15, 2000

ImmunoGen, Inc.
128 Sidney Street
Cambridge, Massachusetts 02139

Ladies and Gentlemen:

    We have acted as counsel to ImmunoGen, Inc., a Massachusetts corporation
(the "Company"), in connection with the preparation and filing with the
Securities and Exchange Commission of a Registration Statement on Form S-3 (the
"Registration Statement"), pursuant to which the Company is registering under
the Securities Act of 1933, as amended, a total of 4,600,000 shares (the
"Shares") of its common stock, $.01 par value per share (the "Common Stock"),
for sale to the public. This opinion is being rendered in connection with the
filing of the Registration Statement.

    In connection with this opinion, we have examined the Company's Restated
Articles of Organization and By-Laws, both as currently in effect; such other
records of the corporate proceedings of the Company and certificates of the
Company's officers as we have deemed relevant; and the Registration Statement
and the exhibits thereto.

    In our examination, we have assumed the genuineness of all signatures, the
legal capacity of natural persons, the authenticity of all documents submitted
to us as originals, the conformity to original documents of all documents
submitted to us as certified, photostatic or facsimile copies and the
authenticity of the originals of such copies.

    Based upon the foregoing, we are of the opinion that (i) the Shares have
been duly and validly authorized by the Company and (ii) the Shares, when sold,
will be duly and validly issued, fully paid and non-assessable shares of the
Common Stock.

    Our opinion is limited to the laws of The Commonwealth of Massachusetts and
the federal laws of the United States of America, and we express no opinion with
respect to the laws of any other jurisdiction. No opinion is expressed herein
with respect to the qualification of the Shares under the securities or blue sky
laws of any state or any foreign jurisdiction.

                BOSTON  NEW YORK  RESTON  WASHINGTON  NEW HAVEN
<PAGE>
MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.

NOVEMBER 15, 2000
Page 2

    The foregoing opinion is rendered as of the date hereof. We assume no
obligation to update such opinion to reflect any facts or circumstances which
may hereafter come to our attention or changes in the law which may hereafter
occur. We understand that you wish to file this opinion as an exhibit to the
Registration Statement, and we hereby consent thereto. We hereby further consent
to the reference to us under the caption "Legality of Common Stock" in the
prospectus included in the Registration Statement.

                                          Very truly yours,
                                          /s/ Mintz, Levin, Cohn, Ferris,
                                          Glovsky and Popeo, P.C.
            --------------------------------------------------------------------
                                          Mintz, Levin, Cohn, Ferris,
                                          Glovsky and Popeo, P.C.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission